Ukraine has approved unified clinical protocols for the provision of emergency, primary and specialized medical care "Pulmonary hypertension in adults", "Pulmonary hypertension in children" (order of the Ministry of Health of Ukraine No. 813 dated 16.06.2026).
The documents were developed by a multidisciplinary team composed of the best specialists in Ukraine in the fields of cardiology, pulmonology, cardiac surgery, transplantation, therapy and others, taking into account modern principles of evidence-based medicine. Methodological guidance and information support were provided by specialists of the Department of Standards in the Field of Healthcare of the Center.
The goal is to improve the quality of medical care for patients at all levels, reduce mortality and disability, and improve patients' life expectancy.
The protocols provide clinicians with clear algorithms for diagnosis, drug and non-drug treatment, management of complications, indications for surgical and interventional intervention, and transplantation depending on the complexity of the disease and differential patient groups.
At the same time, for practical use by physicians, the evidence-based clinical guideline "Pulmonary Hypertension" is recommended. It is intended to assist in making clinical decisions and to ensure uniform approaches to the diagnosis, treatment and follow-up of patients.
The protocols and the clinical guideline can be reviewed in the Register of Medical Technological Documents of the Center at the link https://www.dec.gov.ua/mtd/legeneva-gipertenziya/
For information
Pulmonary hypertension is a severe progressive pathology characterized by persistent elevation of blood pressure in the pulmonary artery. It can affect patients of any age and is often diagnosed at late stages, which significantly worsens treatment prognoses.
Key risk factors include congenital heart defects, chronic obstructive and restrictive lung diseases, a history of pulmonary artery thromboembolism, HIV infection, the use of certain medicinal products and toxic substances, heredity, etc.
